Descrizione

Asthma and COPD, including emphysema and chronic bronchitis are inflammatory diseases that cause airflow blockage and breathing-related problems. The global asthma and COPD devices market in terms of revenue is set to grow by US$ 2 miliardi durante 2021-2027, crescendo ad un tasso di crescita annuale composto (CAGR) Di 6.2% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix. North America held the highest share in the global asthma and copd devices market, while Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increase in incidence and prevalence of asthma and COPD and growing geriatric population are driving market growth.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2017-2020 e previsione a 2027 covering key market aspects like sales value and volume for asthma and COPD devices. The global asthma and COPD devices market is segmented on the basis of product, applicazione, end user, e regione. Per prodotto, it is categorized into diagnostic devices, and monitoring devices. The diagnostic devices segment held the largest market share in 2020. Tuttavia, the monitoring devices segment is expected to witness the highest CAGR during the forecast period. Per applicazione, the asthma and COPD devices market is divided into asthma, and COPD. The asthma segment accounted for the largest market share in 2020. Based on end user, the asthma and copd devices market is divided into hospitals and clinics, and homecare.

The report has profiled some of the key players of the market such as Becton Dickinson and Company (BD), Draegerwerk AG & Company KGAA, Getinge AB, Invacare Corporation, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, NIHON KOHDEN CORPORATION, Smiths Medical Inc., VYAIRE MEDICAL INC..

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the asthma and COPD devices market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: diagnostic devices, and monitoring devices
Applicazione: asthma, and COPD
Utente finale: hospitals and clinics, and homecare
Regione: Nord America, Asia Pacifico, Europa, and Rest of the World (ROW)
Anni considerati: la presente relazione copre il periodo 2017 A 2027

Principali vantaggi per gli stakeholder

Get a comprehensive picture of the global asthma and COPD devices market
Identificare le strategie regionali e le priorità strategiche sulla base di dati e analisi locali
Individuare i settori in crescita e le tendenze per gli investimenti
Understand what the future of the global asthma and COPD devices market looks like
Identificare il panorama competitivo e la finestra di opportunità

Sommario

1. Definizione del mercato
2. Metodologia di ricerca
3. Dati di mercato & Veduta
3.1 Valore di mercato
3.2 Previsione del valore di mercato
4. Asthma and COPD Devices Market by Product
4.1 Diagnostic Devices
4.2 Monitoring Devices
5. Asthma and COPD Devices Market by Application
5.1 Asthma
5.2 Copd
6. Asthma and COPD Devices Market by End User
6.1 Hospitals And Clinics
6.2 Homecare
7. Asthma and COPD Devices Market by Region
7.1 Nord America
7.2 Asia Pacifico
7.3 Europa
7.4 Rest Of The World (Row)
8. Profili aziendali
8.1 Becton, Dickinson and Company (BD)
8.2 Draegerwerk AG & Company KGAA
8.3 Getinge AB
8.4 Invacare Corporation
8.5 Koninklijke Philips N.V.
8.6 Masimo Corporation
8.7 Medtronic plc
8.8 NIHON KOHDEN CORPORATION
8.9 Smiths Medical, Inc.
8.10 VYAIRE MEDICAL INC.
9. Appendice
9.1 Informazioni su StrategyHelix
9.2 Disclaimer